Local consolidative therapy for oligometastatic patients with stage IV non-small cell lung cancer may improve survival, but unanswered questions remain

被引:1
|
作者
Pacheco, Jose M. [1 ]
Moghanaki, Drew [2 ,3 ]
机构
[1] Univ Colorado, Dept Internal Med, Div Med Oncol, Anschutz Canc Ctr, Aurora, CO USA
[2] Emory Univ, Sch Med, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA USA
[3] Atlanta Vet Affairs Hlth Care Syst, Dept Radiat Oncol, Decatur, GA USA
关键词
STEREOTACTIC BODY RADIOTHERAPY; RADIATION-THERAPY; TRIAL;
D O I
10.21037/tlcr.2019.06.07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S407 / S411
页数:5
相关论文
共 50 条
  • [41] Factors Associated With Survival in Patients With Oligometastatic Non-Small Cell Lung Cancer (NSCLC)
    Parikh, R. B.
    Cronin, A.
    Kozono, D. E.
    Oxnard, G. R.
    Mak, R. H.
    Jackman, D. M.
    Lo, P. C.
    Baldini, E. H.
    Johnson, B. E.
    Chen, A. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S202 - S202
  • [42] Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer
    Yano, Tokujiro
    Okamoto, Tatsuro
    Haro, Akira
    Fukuyama, Seiichi
    Yoshida, Tsukihisa
    Kohno, Mikihiro
    Maehara, Yoshihiko
    LUNG CANCER, 2013, 82 (03) : 431 - 435
  • [43] Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational study
    Chen, Ya
    Wang, Yanan
    Yang, Zhengyu
    Hu, Minjuan
    Lu, Jun
    Zhang, Yanwei
    Qian, Fangfei
    Zhang, Bo
    Wang, Shuyuan
    Wang, Kai
    Zhang, Wei
    Han, Baohui
    THORACIC CANCER, 2022, 13 (05) : 732 - 741
  • [44] RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit from Local Consolidative Treatment
    Zhang, J.
    Tang, Y.
    Liu, S.
    Dong, S.
    Yang, X.
    Wu, Y.
    Zhong, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S447 - S448
  • [45] Radiotherapy for oligometastatic non-small cell lung cancer patients
    Levy, A.
    Roux, C.
    Mercier, O.
    Issard, J.
    Botticella, A.
    Barlesi, F.
    Le Pechoux, C.
    CANCER RADIOTHERAPIE, 2021, 25 (6-7): : 517 - 522
  • [46] The multimodality therapy for patients with advanced non-small cell lung cancer (stage IIIB and IV).
    Guo, H
    Li, Z
    Cheng, H
    Sun, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 707S - 707S
  • [47] Local ablative radiotherapy for oligometastatic non-small cell lung cancer
    Suh, Yang-Gun
    Cho, Jaeho
    RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 149 - 155
  • [48] Definitive Dose Thoracic Radiotherapy In Oligometastatic Stage IV Non-small Cell Lung Cancer (NSCLC)
    Xanthopoulos, E.
    Fernandes, A. T.
    Apisarnthanarax, S.
    Christodouleas, J.
    Eaby-Sandy, B.
    Langer, C. J.
    Evans, T. L.
    Lin, L.
    Hahn, S. M.
    Rengan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S620 - S620
  • [49] Definitive Primary Therapy in Patients Presenting With Oligometastatic Non-Small Cell Lung Cancer
    Lo, Simon S.
    Rodrigues, George B.
    Lock, Michael
    Palma, David A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (03): : 716 - 717
  • [50] Definitive Primary Therapy in Patients Presenting With Oligometastatic Non-Small Cell Lung Cancer
    Parikh, Ravi B.
    Cronin, Angel M.
    Kozono, David E.
    Oxnard, Geoffrey R.
    Mak, Raymond H.
    Jackman, David M.
    Lo, Peter C.
    Baldini, Elizabeth H.
    Johnson, Bruce E.
    Chen, Aileen B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (04): : 880 - 887